Jasper Therapeutics Files 2024 Annual Report
Ticker: JSPRW · Form: 10-K · Filed: Feb 28, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | 10-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotech
TL;DR
Jasper Therapeutics filed its 2024 10-K. All systems go.
AI Summary
Jasper Therapeutics, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware, is involved in the biological products sector. Its principal executive offices are located at 2200 Bridge Parkway, Suite #102, Redwood City, CA 94065, with a contact phone number of (650) 549-1400.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Jasper Therapeutics' financial performance and operational status for the fiscal year 2024.
Risk Assessment
Risk Level: low — This is a standard annual report filing with no immediate red flags or significant new information presented in the header.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report)
- 93 — Public Document Count (Indicates the volume of documents associated with this filing)
- 20250228 — Filing Date (The date the report was submitted to the SEC)
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Filer and subject of the report
- 2024 (date) — Fiscal year end
- 2200 Bridge Pkwy Suite #102 Redwood City, CA 94065 (location) — Principal executive offices address
- 84-2984849 (identifier) — IRS Employer Identification No.
- 001-39138 (identifier) — Commission File Number
FAQ
What is the primary business of Jasper Therapeutics, Inc.?
Jasper Therapeutics, Inc. is primarily involved in the biological products sector, specifically categorized under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
When did Jasper Therapeutics, Inc. change its former name?
The company formerly known as Amplitude Healthcare Acquisition Corp. changed its name on September 12, 2019.
What is the physical address of Jasper Therapeutics' principal executive offices?
The principal executive offices are located at 2200 Bridge Pkwy Suite #102, Redwood City, CA 94065.
What is the SEC file number for Jasper Therapeutics, Inc.?
The Commission File Number for Jasper Therapeutics, Inc. is 001-39138.
What is the fiscal year end date for this 10-K filing?
The 10-K filing is for the fiscal year ended December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).